Drug name - Savella

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6602911 ALLERGAN Methods of treating fibromyalgia Jan, 2023

(3 months from now)

US7994220 ALLERGAN Milnacipran for the long-term treatment of fibromyalgia syndrome Sep, 2029

(6 years from now)

Drugs and Companies using MILNACIPRAN HYDROCHLORIDE ingredient

Treatment: Management of fibromyalgia (fm); Management of fibromyalgia


More Information on Dosage
Strength Dosage Availability
12.5MG TABLET;ORAL Prescription
25MG TABLET;ORAL Prescription
50MG TABLET;ORAL Prescription
100MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.